Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E V Loftus

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Alimentary Pharmacology & Therapeutics|January 26, 2013
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel diseaseJ B Kisiel, T C Yab, F T Nazer Hussain, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Endoscopy|July 10, 2009
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensusA Bourreille, A Ignjatovic, L Aabakken, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Alimentary Pharmacology & Therapeutics|January 26, 2013
Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel diseaseJ B Kisiel, T C Yab, F T Nazer Hussain, et al.
Alimentary Pharmacology & Therapeutics|June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 studyW J Sandborn, G Y Melmed, D P B McGovern, et al.
Endoscopy|July 10, 2009
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensusA Bourreille, A Ignjatovic, L Aabakken, et al.
The American Journal of Gastroenterology|August 26, 2015
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetL Peyrin-Biroulet, W Sandborn, B E Sands, et al.
Pageof 8